Physician profile
David J Hernandez
NPI 1063564060
$23,323.97
in general payments reported to CMS, 2019-2025
21 companies · $2,421 in 2025
The $2,421 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,745 · 2020: $648 · 2021: $757 · 2022: $6,560 · 2023: $3,255 · 2024: $2,937 · 2025: $2,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,050 · Food and Beverage: $3,459 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900 · Travel and Lodging: $170 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,050.00 |
| Food and Beverage | $3,458.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
| Travel and Lodging | $169.89 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $9,900.00 | 2022-2025 | Glidesheath Slender, Azur Cx Detachable |
| Travere Therapeutics, INC. | $5,635.07 | 2019-2020 | |
| Boston Scientific Corporation | $3,219.88 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Stone Cone |
| Coloplast Corp | $1,192.36 | 2019-2024 | Titan, Speedicath, Peristeen |
| Procept Biorobotics Corporation | $688.31 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Calyxo, INC. | $581.64 | 2021-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $421.18 | 2019-2023 | Xtandi |
| Ambu INC. | $407.67 | 2023-2025 | |
| Karl Storz Endoscopy-America | $247.40 | 2019-2023 | Hopkins |
| Photocure INC | $213.72 | 2019-2022 | |
| Innovation Technologies INC | $169.29 | 2025 | Irrisept |
| Neotract INC. | $138.91 | 2019 | |
| Endo USA, INC. | $132.89 | 2025 | Xiaflex |
| Laborie Medical Technologies Corp. | $98.86 | 2023 | |
| Janssen Biotech, INC. | $98.14 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $48.66 | 2023-2024 | Lofric, Lofric |
| C. R. Bard, INC. & Subsidiaries | $38.38 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Novo Nordisk INC | $32.27 | 2024 | |
| Teleflex LLC | $24.28 | 2025 | Urolift |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.